Corrigendum: Patients Benefit From Genetics‐Guided Coumarin Anticoagulant Therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|96|3|397-397

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.96, Iss.3, 2014-09, pp. : 397-397

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patients Benefit From Genetics‐Guided Coumarin Anticoagulant Therapy

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 1, 2014-07 ,pp. : 15-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lung cancer patients with an abnormal gene benefit from targeted therapy

By  

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3582-3582

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anticoagulant Therapy

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 35, Iss. 4, 1987-04 ,pp. : 369-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rationalized DNA sequencing-based protocol for genotyping patients receiving coumarin therapy

By Rakicevic Ljiljana B.   Kusic-Tisma Jelena S.   Kovac Mirjana K.   Backovic Dragana T.   Radojkovic Dragica P.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 73, Iss. 6, 2013-09 ,pp. : 523-527

Informa Healthcare

Access to resources Recommend Favorite

Which Panic Disorder Patients Benefit from Which Treatment: Cognitive Therapy or Antidepressants?

By  

Psychotherapy and Psychosomatics, Vol. 76, Iss. 3, 2007-04 ,pp. : 154-161

Karger

Access to resources Recommend Favorite